Background: Ginsenoside Rh2 (Rh2) is a major biological component of ginseng that exerts antitumor activities in multiple cancers including Non-Small Cell Lung Cancers (NSCLCs). Rh2 also enhances the anti-tumor effects of various chemotherapy drugs including cisplatin at relatively low concentrations. Here, the mechanistic role of Rh2 in chemotherapy-treated NSCLCs will be investigated.
Methods: In this study, FACS, western blot and siRNA addition were used to analyze the role of Rh2 in cisplatin- treated lung adenocarcinoma A549 and H1299 cells.
Results: Subsequent observations indicated that Rh2 enhanced cisplatin-induced NSCLCs A549 and H1299 cells apoptosis. Cisplatin-induced productive autophagy was repressed by Rh2 in A549 cells. Rh2 also enhanced cisplatin cytotoxicity by elevating superoxide dismutase activity and repressing cisplatin-induced superoxide generation. Conversely, Rh2 was found to repress cisplatin-induced phosphorylation of epidermal growth factor receptor, phosphoinositide 3-kinase, protein kinase B, and autophagy. Cisplatin-induced Programmed Death- Ligand 1 (PD-L1) expression was repressed by Rh2 via the superoxide.
Conclusion: These findings suggest that Rh2 enhanced the function of cisplatin by repressing superoxide generation, PD-L1 expression, and autophagy in lung adenocarcinoma cells.
[http://dx.doi.org/10.1200/JCO.2007.13.9030] [PMID: 18506026]
[http://dx.doi.org/10.1038/cddis.2011.129] [PMID: 22170099]
[http://dx.doi.org/10.1371/journal.pone.0181081] [PMID: 28746345]
[http://dx.doi.org/10.1016/j.ejmech.2015.08.032] [PMID: 26312433]
[http://dx.doi.org/10.1038/srep32213] [PMID: 27573798]
[http://dx.doi.org/10.1158/2326-6066.CIR-17-0235] [PMID: 29097421]
[http://dx.doi.org/10.1016/j.cell.2017.09.028] [PMID: 29033130]
[http://dx.doi.org/10.1016/j.fct.2017.02.020] [PMID: 28223119]
[http://dx.doi.org/10.1371/journal.pone.0081162] [PMID: 24260552]
[http://dx.doi.org/10.18632/oncotarget.19201] [PMID: 28969040]
[http://dx.doi.org/10.1097/00001813-199102000-00009] [PMID: 1958854]
[http://dx.doi.org/10.1021/acs.jmedchem.8b00669] [PMID: 30091915]
[http://dx.doi.org/10.1158/0008-5472.CAN-14-3362] [PMID: 26637667]